- Livongo Announces New Voice-Enabled Hypertension System Powered by Amazon Lex and Amazon Polly
- Attendees include Livongo Clients and Members Combined with Leading Behavioral and Data Scientists, Clinicians, Healthcare Thought Leaders, Venture Capitalists, and Media
San Francisco, CA – February 28, 2019 – Livongo, the leading Applied Health Signals™ company empowering people with chronic conditions to live better and healthier lives, today announced the start of the invitation-only SIGNUM 2019 conference, being held in San Francisco. The conference brings together more than 200 of Livongo’s clients and Members, leading behavioral and data scientists, clinicians, healthcare thought leaders, venture capitalists, and media to participate in interactive and interdisciplinary discussions addressing our nation’s chronic condition epidemic. The conference will also include extensive hands-on, experiential, and small-group sessions to stimulate new connections and approaches to managing chronic conditions.
Despite the investment and advances in technology, our healthcare system is failing to adequately address the current chronic condition epidemic. Today, approximately 180 million Americans are suffering from at least one chronic condition and 75 percent of all healthcare industry spending is related to chronic conditions. Livongo is enabling its Members to make important health changes by aggregating and interpreting data, and by delivering health signals in the way most useful to the Member managing their condition. Its Applied Health Signals solution is leading to a better Member experience and improved clinical and financial outcomes.
“Livongo is on a mission to transform the healthcare experience for millions of people living with chronic conditions every day,” said Livongo Executive Chairman Glen Tullman. “SIGNUM is about bringing our clients and Members together with industry leaders across a wide spectrum of disciplines to make healthcare less confusing, less complex, and less costly for everyone. Our goal is to further the conversation and create a community of key stakeholders committed to advancing Applied Health Signals solutions and making it easier for people living with chronic conditions to get and stay healthy.”
SIGNUM will include keynotes from healthcare industry thought leaders including Aneesh Chopra, President of CareJourney and former United States Chief Technology Officer, Mark Ganz, President and Chief Executive Officer of Cambia Health Solutions, Stephen K. Klasko, M.D., MBA, President of Thomas Jefferson University and CEO of Jefferson Health, Hemant Taneja, Managing Director of General Catalyst, and executives from Abbott Diabetes Care, Delta, Hewlett Packard Enterprises, SAP, US Foods, Voya, and Willis Towers Watson. SIGNUM will also feature experts from outside the healthcare industry including New York Times best-selling authors Daniel Pink, whose recent book When: The Scientific Secrets of Perfect Timing, explores why when you do something may matter as much as what you do, and Seth Stephens-Davidowitz, whose recent book Everybody Lies: Big Data, New Data, and What the Internet Can Tell Us About Who We Really Are, explores what people do versus what they tell us they do, both relevant for an industry trying to promote healthy behaviors. 150 West Evelyn Ave, Suite 150, Mountain View, CA 94041 (866) 435-5643 livongo.com
“Livongo is creating a truly consumer-friendly solution to drive positive outcomes for their Members managing their chronic conditions in their daily lives. We are seeing these results through our own use of Livongo to support our employees and enable them to better manage their diabetes and reduce their healthcare costs,” said Stephen K. Klasko, M.D., MBA, President of Thomas Jefferson University and CEO of Jefferson Health. “By better understanding how their advanced Applied Health Signals solution is actually used, Livongo can provide the support that people living with chronic conditions need during the vast majority of time they spend outside of an actual clinical setting.”
During SIGNUM, Livongo will demonstrate its full product suite and present new product innovations, which harness the power of Applied Health Signals, a new category of technologies and capabilities that combines data science, behavior enablement, and clinical impact to reinvent the healthcare experience for people with chronic conditions.
New Voice-enabled Cellular Blood Pressure Monitoring System Powered by Amazon Lex and Amazon Polly
As voice increasingly becomes one of the preferred ways people interact with technology, Livongo announced that it will leverage Amazon Lex and Amazon Polly to power its voice-enabled cellular blood pressure monitoring system.
For example, after a high blood pressure reading, the Member may hear a voice Health Nudge suggesting changes to their nutrition to help lower sodium intake. The Livongo for Hypertension voice experience will provide Members the ability to easily interact with Livongo via the most natural and personalized communication channel – their voice. This innovation enables a new way to deliver actionable, personalized, and timely health signals that drive behavior change and positive clinical outcomes.
“SIGNUM brings our Members, partners, clients, and industry innovators together to discuss how we can continue transforming the healthcare experience for people living with chronic conditions,” said Dr. Jennifer Schneider, M.D., M.S., President of Livongo. “Our new Amazon Lex and Amazon Polly powered cellular blood pressure monitoring system is a great example of the collaborative efforts Livongo is taking to advance healthcare and reach more people who prefer voice as their primary communication channel.”
Livongo offers a whole person platform that empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health. Livongo pioneered the new category of Applied Health Signals to silence Noisy Healthcare™. Our team of data scientists
 Buttorff C, Ruder T, Bauman M. Multiple Chronic Conditions in the United States[PDF – 392 KB]. Santa Monica, CA: Rand Corp.; 2017
 Any Menta lIllness (AMI) Among Adults.(n.d.).Retrieved October 23, 2015, from http://www.nimh.nih.gov/health/statistics/prevalence/any-mental-illness-ami-among-adults.shtml
 Center for Medicare & Medicaid Services. National Health Expenditure Data for 2016—Highlights[PDF – 74 KB].
 Presentation at the 77th Annual American Diabetes Association’s Scientific Sessions.
 Downing J, Bollyky J, Schneider J. Use of a Connected Glucose Meter and Certified Diabetes Educator Coaching to Decrease the Likelihood of Abnormal Blood Glucose Excursions: The Livongo for Diabetes Program. J Med Internet Res 2017;19(7):e234, DOI: 10.2196/jmir.6659
Amazon Lex is not an AWS HIPAA Eligible Service at the time of this writing. Consistent with the AWS Business Associate Addendum (BAA), Amazon Lex should not be used to create, receive, maintain, or transmit Protected Health Information (PHI) under the U.S. Health Insurance Portability and Accountability Act (HIPAA). It is each customer’s responsibility to determine whether they are subject to HIPAA, and if so, how best to comply with HIPAA and its implementing regulations. Accounts that create, receive, maintain, or transmit PHI using a HIPAA Eligible Service should encrypt PHI as required under the BAA. For a current list of HIPAA Eligible Services, and for more information generally, see the AWS HIPAA Compliance page.